Novo Integrated Sciences ROE 2012-2024 | NVOS
Current and historical return on equity (ROE) values for Novo Integrated Sciences (NVOS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Novo Integrated Sciences ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-08-31 | $-0.02B | $0.02B | -97.14% |
| 2024-05-31 | $-0.03B | $0.02B | -126.58% |
| 2024-02-29 | $-0.01B | $0.02B | -50.53% |
| 2023-11-30 | $-0.01B | $0.03B | -56.00% |
| 2023-08-31 | $-0.01B | $0.03B | -53.06% |
| 2023-05-31 | $-0.03B | $0.02B | -133.33% |
| 2023-02-28 | $-0.04B | $0.03B | -122.81% |
| 2022-11-30 | $-0.04B | $0.03B | -106.06% |
| 2022-08-31 | $-0.03B | $0.04B | -85.16% |
| 2022-05-31 | $-0.01B | $0.04B | -29.38% |
| 2022-02-28 | $-0.01B | $0.04B | -21.18% |
| 2021-11-30 | $-0.01B | $0.04B | -12.99% |
| 2021-08-31 | $0.00B | $0.04B | -11.51% |
| 2021-05-31 | $-0.01B | $0.03B | -19.20% |
| 2021-02-28 | $-0.01B | $0.03B | -20.17% |
| 2020-11-30 | $-0.01B | $0.03B | -20.00% |
| 2020-08-31 | $-0.01B | $0.03B | -17.09% |
| 2020-05-31 | $0.00B | $0.03B | -3.54% |
| 2020-02-29 | $0.00B | $0.03B | -3.74% |
| 2019-11-30 | $0.00B | $0.03B | 0.00% |
| 2019-08-31 | $0.00B | $0.02B | 0.00% |
| 2019-05-31 | $0.00B | $0.01B | 0.00% |
| 2019-02-28 | $0.00B | $0.01B | 0.00% |
| 2018-11-30 | $0.00B | 0 | -400.00% |
| 2018-08-31 | $0.00B | $0.00B | 100.00% |
| 2018-05-31 | $0.00B | $0.00B | 100.00% |
| 2018-02-28 | $0.00B | $0.00B | 61.54% |
| 2017-11-30 | $0.00B | $0.00B | 30.77% |
| 2017-08-31 | $0.00B | $0.00B | 44.44% |
| 2017-03-31 | $0.00B | 0 | 0.00% |
| 2017-02-28 | $0.00B | 0 | 0.00% |
| 2016-11-30 | $0.00B | 0 | 0.00% |
| 2016-09-30 | $0.00B | 0 | 0.00% |
| 2016-05-31 | $0.00B | 0 | 0.00% |
| 2016-03-31 | $0.00B | 0 | 0.00% |
| 2015-06-30 | $0.00B | -0 | 800.00% |
| 2015-03-31 | $0.00B | $0.00B | 400.00% |
| 2014-06-30 | $0.00B | $0.00B | 0.00% |
| 2014-03-31 | $0.00B | $0.00B | 0.00% |
| 2013-09-30 | $0.00B | $0.00B | 0.00% |
| 2013-06-30 | $0.00B | $0.00B | 0.00% |
| 2012-12-31 | $0.00B | $0.00B | 0.00% |
| 2012-09-30 | $0.00B | $0.00B | 0.00% |
| 2012-03-31 | $0.00B | $0.00B | 100.00% |
| 2012-02-29 | $0.00B | $0.00B | 400.00% |
| 2011-11-30 | $0.00B | 0 | 0.00% |
| 2011-09-30 | $0.00B | 0 | 0.00% |
| 2011-08-31 | $0.00B | 0 | 0.00% |
| 2011-06-30 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.013B |
| Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |